Research Article
Use of Long-Acting Injectable Antipsychotic in an Inpatient Unit of a Community Teaching Hospital
Table 1
Demographic information of study subjects.
| | Characteristic | All Patients | Patients with SSD | Patients who received a LAI (n = 19) | | (n = 61) | (n = 43) |
| | Gender (%) | | | | | (i) Female | 18 (30) | 10 (23) | 3 (16) | | (ii) Male | 43 (70) | 33 (77) | 16 (84) |
| | Mean age, years (range) | 41 (20—71) | 41 (20—71) | 39 (20—71) |
| | Race (%) | | | | | (i) Black | 49 (80) | 35 (81) | 17 (89) | | (ii) White | 11 (18) | 8 (19) | 2 (11) | | (iii) Others | 1 (2) | 0 (0) | 0 (0) |
| | Unemployed (%) | 56 (91) | 41 (95) | 19 (100) |
| | Readmission within 30 days of last discharge | 25 (41) | 20 (47) | 11 (58) |
| | Homeless | 32 (52) | 26 (60) | 10 (53) |
| | Average length of stay, days | 14 | 16 | 18 | | Median length of stay, days | 11 | 13 | 14 |
| | Co-occurring substance use disorder (%) | | | | (i) Tobacco | 38/56 (68) | 25/39 (64) | 11/17 (65) | | (ii) Cannabis | 26/55 (47) | 19/40 (48) | 7/18 (39) | | (iii) Alcohol | 14/55 (25) | 8/39 (21) | 4/17 (24) | | (iv) Cocaine | 8/55 (15) | 4/40 (10) | 1/18 (6) | | (v) Synthetic Cannabinoids | 2/55 (4) | 2/40 (5) | 1/18 (6) | | (vi) Amphetamine | 1/55 (2) | 1/40 (3) | 0/18 (0) | | (vii) Any substance | 49/58 (84) | 33/41 (80) | 13/18 (68) |
|
|
Proportions calculated after missing values were excluded. |
